| Literature DB >> 12894125 |
Stephanie L Mehlis1, Kenneth B Gordon.
Abstract
In this review, we will discuss the immunological basis for psoriasis with special emphasis on the role of effector T cells. With the understanding of this immunologic process, we will present a model for the development of targeted immune response modifiers, termed biologic immunotherapies, and their potential role for the benefit of patients with psoriasis.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12894125 DOI： 10.1016/s0190-9622(03)01134-4
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527